| Literature DB >> 30889638 |
Mirana Taz1, Preeti Makkar2, Khan Mohammad Imran3, D W Jang2, Yong-Sik Kim4, Byong-Taek Lee5.
Abstract
The present work is to investigate the efficiency of hyaluronic acid (HyA) supplemented biphasic calcium phosphate (BCP) injectable granule to promote the bone regeneration. The effect of adding HyA to the multichannel BCP granule (MCG-HyA) was studied in terms of morphology, chemical structure, porosity, in-vitro and in-vivo biocompatibility, RT-PCR, western blot and compared with MCG. The addition of HyA to MCG successfully made the granules injectable type. In-vivo studies in rabbit model showed an enhancement in bone formation after 4 weeks of implantation and better handling characteristics for MCG-HyA than MCG. RT-PCR and Western Blotting studies revealed that MCG-HyA significantly unregulated the osteogenic gene and protein expressions respectively. Our results indicated that MCG-HyA could be used as a promising injectable bone substitute in clinical applications.Entities:
Keywords: BCP granule; Hyaluronic acid; Injectable bone substitute; MCG-HyA
Mesh:
Substances:
Year: 2019 PMID: 30889638 DOI: 10.1016/j.msec.2019.02.051
Source DB: PubMed Journal: Mater Sci Eng C Mater Biol Appl ISSN: 0928-4931 Impact factor: 7.328